Elevated Tryptase Levels Are Associated with Greater Bone Density in a Cohort of Patients with Mastocytosis

Abstract

Background: Mastocytosis is associated with a pathological increase in tissue mast cells. Associated skeletal problems include a decrease in bone density and pathological fractures. Methods: In order to explore the relationship between bone density and the severity of mastocytosis, 21 patients with mastocytosis who underwent dual-energy X-ray absorptiometry were entered into this study. Correlation coefficients were computed between Z-scores and demographic, clinical and laboratory data. Femoral neck Z-scores correlated with serum tryptase levels when all the patients were considered (p = 0.029). Results and Conclusion: Patients with less severe disease had significantly lower values at the L1–L4 spine (p = 0.046) and femoral neck (p = 0.029) Z-scores compared to patients with more severe disease. Most patients who had low Z-scores (between –1 and –2.5) were under 50 years of age, had less severe disease and had lower serum tryptase levels. A history of gastroesophageal reflux disease and a history of hypotensive episodes correlated with lower L1–L4 spine Z-scores (p < 0.05). Thus, patients with less severe disease and lower serum tryptase levels should in particular have their bone density determined with treatment appropriate to the findings.